These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18269615)
1. Superficial migratory thrombophlebitis in a hypertensive patient: response to antihypertensive therapy. Laguna C; Pérez-Ferriols A; Alegre V J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):383-4. PubMed ID: 18269615 [No Abstract] [Full Text] [Related]
2. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684 [TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589 [TBL] [Abstract][Full Text] [Related]
4. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428 [TBL] [Abstract][Full Text] [Related]
5. [Noonan syndrome coexisting with essential arterial hypertension in 8 year old boy]. Rokicki W; Rokicka A Wiad Lek; 2002; 55(7-8):488-93. PubMed ID: 12428579 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension. Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311 [TBL] [Abstract][Full Text] [Related]
7. Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men. Nandeesha H; Pavithran P; Madanmohan T Angiology; 2009; 60(2):217-20. PubMed ID: 18445617 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203 [TBL] [Abstract][Full Text] [Related]
9. [Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs]. Lazebnik LB; Mikheeva OM; Drozdov VN; Petrakov AV; Sil'vestrova SIu Eksp Klin Gastroenterol; 2008; (2):22-6. PubMed ID: 19148988 [No Abstract] [Full Text] [Related]
10. Atenolol versus other beta-adrenergic blockers. Aursnes I; Osnes JB J Am Coll Cardiol; 2009 Jun; 53(22):2101-2; author reply 2106-7. PubMed ID: 19477363 [No Abstract] [Full Text] [Related]
11. Hypertension recurrence in patients receiving anti-hypertensive therapy. Frankel TN; Modlinger RS J Med Soc N J; 1978 Aug; 75(9):606-9. PubMed ID: 277700 [No Abstract] [Full Text] [Related]
12. Atenolol is dead: long live beta-blockade. Cockcroft JR J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365 [No Abstract] [Full Text] [Related]
13. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension. Sever PS; Poulter NR; Dahlof B; Wedel H; J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984 [TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. Olsen MH; Wachtell K; Beevers G; Dahlöf B; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Narayan P; Nieminen MS; Omvik P; Oparil S; Wedel H Am Heart J; 2009 Jan; 157(1):177-84. PubMed ID: 19081416 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB; Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468 [TBL] [Abstract][Full Text] [Related]
16. Diabetes and hypertension: which is the best approach? Escobar C; Barrios V Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):269-71. PubMed ID: 19296764 [TBL] [Abstract][Full Text] [Related]
17. Older age should not be a barrier to the treatment of hypertension. Aronow WS Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394 [TBL] [Abstract][Full Text] [Related]
18. Effects of atenolol and propanolol on platelet aggregation in moderate essential hypertension. Beyan C; Kaptan K; Ifran A Croat Med J; 2005 Aug; 46(4):695-6; author reply 696-7. PubMed ID: 16161254 [No Abstract] [Full Text] [Related]
19. Hypertension in the elderly: new and old evidence that treatment may benefit the old. Fagard RH J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990 [TBL] [Abstract][Full Text] [Related]
20. Slower heart rates for healthy hearts: time to redefine tachycardia? Gopinathannair R; Sullivan RM; Olshansky B Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):321-3. PubMed ID: 19808425 [No Abstract] [Full Text] [Related] [Next] [New Search]